Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

BACKGROUND: Although serotonin reuptake inhibitors are effective in the treatment of OCD, many patients fail to respond to these agents. Growing evidence from open-label and placebo-controlled trials suggests a role for augmentation of SRIs with atypical antipsychotics in OCD. Quetiapine is generall...

ver descrição completa

Detalhes bibliográficos

Publicado no:	BMC Psychiatry
Principais autores:	Carey, Paul D, Vythilingum, Bavanisha, Seedat, Soraya, Muller, Jacqueline E, van Ameringen, Michael, Stein, Dan J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2005
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC547907/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15667657/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-244X-5-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!